BioGENext
Conference 2024
BioGENext Conference 2024 was the inaugural international conference dedicated to next-generation therapy development, bringing together academia and industry to discuss cutting-edge advances in gene editing, nucleic acid and recombinant protein therapeutics, bioinformatics, and translational biomedical research.
Held on September 17–20, 2024 in Kyiv, the conference took place in a hybrid format. The program featured keynote lectures, thematic sessions, flash talks, workshops, and poster discussions, fostering active scientific exchange.
BioGENext 2024 in Numbers
845
registered participants
400
onsite participants
40
international speakers
25
countries represented
Keynote Speakers
Ben Kleinstiver
Dr., Kayden-Lambert MGH Research Scholar. Associate Investigator, Massachusetts General Hospital. Associate Professor, Harvard Medical School, Center for Genomic Medicine & Department of Pathology, USA
Janusz M. Bujnicki
Prof., Head of the Laboratory of Bioinformatics and Protein Engineering at the International Institute of Molecular and Cell Biology in Warsaw, Poland
Frank Buchholz
Professor of Medical Systems Biology and Head of Translational Research at the University Cancer Center (UCC) of TU Dresden, Germany
Omar O. Abudayyeh
Dr., Co-Founder, Sherlock Biosciences, Abudayyeh-Gootenberg Laboratory, McGovern Institute for Brain Research at MIT, Assistant Professor at Harvard Medical School, USA
Jonathan Gootenberg
Dr., Co-Founder, Sherlock Biosciences, Abudayyeh-Gootenberg Laboratory, McGovern Institute for Brain Research at MIT, USA
September 17-20, 2024
Unit City
Kyiv, Ukraine
BioGENext Conference 2024
BioGеNext Conference 2024
